Clinical trial

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

NCT00365781

Study summary

ClinicalTrials.gov

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention ISIS 113715 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-08-01

PhasePHASE1

Conditions

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Interventions

ISIS 113715DRUG

Sponsors & collaborators

Ionis Pharmaceuticals, Inc.lead sponsor

Mapped research locations

San DiegoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00365781 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.